atomoxetine hydrochloride has been researched along with Ischemic Attack, Transient in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH; Choi, SY; Hong, S; Kang, IJ; Kim, SK; Kim, YH; Kim, YM; Lee, CH; Lee, TK; Park, JH; Won, MH | 1 |
| Ahn, JH; Chen, BH; Cho, JH; Kim, IH; Kim, SK; Kim, YM; Lee, CH; Lee, JC; Lee, YL; Park, JH; Shin, BN; Tae, HJ; Won, MH | 1 |
| Bangs, ME; Chaudhry, S; Holick, CN; Jones, ME; Seeger, JD; Turnbull, BR | 1 |
3 other study(ies) available for atomoxetine hydrochloride and Ischemic Attack, Transient
| Article | Year |
|---|---|
Atomoxetine Protects Against NMDA Receptor-mediated Hippocampal Neuronal Death Following Transient Global Cerebral Ischemia.
Topics: Animals; Atomoxetine Hydrochloride; bcl-2-Associated X Protein; Cell Death; Disease Models, Animal; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Motor Activity; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Proto-Oncogene Proteins c-bcl-2; Receptors, N-Methyl-D-Aspartate; Time Factors | 2017 |
Neuroprotection and reduced gliosis by atomoxetine pretreatment in a gerbil model of transient cerebral ischemia.
Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoresceins; Gerbillinae; Glial Fibrillary Acidic Protein; Gliosis; Ischemic Attack, Transient; Male; Microfilament Proteins; Neuroprotective Agents; Phosphopyruvate Hydratase | 2015 |
Atomoxetine and cerebrovascular outcomes in adults.
Topics: Adolescent; Adult; Aged; Atomoxetine Hydrochloride; Cohort Studies; Databases, Factual; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Propylamines; Risk Factors; Stroke; Treatment Outcome; Young Adult | 2009 |